Assessing Neurodevelopment in Congenital Heart Disease.
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 250 participants.
Also called NCT02996630
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 250 participants
- Sponsor
- Registry
-
NCT02996630
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Spain
- Registry status
- Unknown status
Technical summary
Registry record NCT02996630. Non-randomized; no masking; primary purpose diagnostic. Start 2013-05 (registry gives no type); primary completion 2017-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Assessing Neurodevelopment in Congenital Heart Disease.
- Acronym
- NEUROHEART
- Condition
- Congenital Heart Disease
- Intervention (Procedure)
- Sonography
- Intervention (Device)
- Magnetic Resonance Imaging
- Intervention (Other)
- Bailey Test
- Intervention (Procedure)
- Surgical intervention
- Intervention (Procedure)
- Brain monitoring
- Intervention (Procedure)
- cord blood sample
- Lead sponsor
- Hospital Universitari Vall d'Hebron Research Institute
- Collaborator
- Hospital Sant Joan de Deu
- Collaborator
- Hospital Universitario La Paz
- Collaborator
- Hospital Universitario 12 de Octubre
- Collaborator
- Hospital General Universitario Gregorio Marañon
- Collaborator
- Fundacion Dexeus
Record details
- Record id
cardio:ct-nct02996630- Content hash
63340561b17e421c2ba4973112c75c7964b8850baac734c83f48a36a7eb8b47d